Discusses Digital PCR Technology and Applications in Environmental Sample Analysis June 15, 2026 10:00 AM EDTCompany ...
Phase II study of decitabine and gemtuzumab ozogamicin (GO) in acute myelogenous leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Background: CML patients with different types of BCR-ABL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results